NCT00918879 - Evaluate Saxagliptin in Adult Indian Patients With Type 2 Diabetes Inadequate Glycemic Control | Biotech Hunter

Enrollment

213

Participants

Timeline

Start Date

May 31, 2009

Primary Completion Date

July 31, 2010

Study Completion Date

July 31, 2010

Conditions

Type 2 Diabetes

Interventions

DRUG

Saxagliptin

Oral tablet, once daily for 24 weeks

DRUG

Placebo

Oral tablet, once daily for 24 weeks

Trial Locations (9)

Research Site, Gujarat

Research Site, Karnataka

Research Site, Tamil Nadu

Research Site, Andhra Pradesh

Research Site, Madhya Pradesh

Research Site, Haryāna

Research Site, Kerala

Research Site, Maharashtra